USPTO serial 97353799
AOBIOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 18, 2025
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AOBIOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CAMBRIDGE, MA, US
Cambridge, MA, US
Cambridge, MA, US
Cambridge, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ann Lamport Hammitte
Ann Lamport Hammitte LANDO & ANASTASI, LLP60 STATE STREET, 23RD FLOORBOSTON, MA 02109United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing | ACTIVE | Sep 12, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 25, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 25, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 18, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 17, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 1, 2024 | IUAF | USE AMENDMENT FILED | — |
| Nov 1, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 31, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 31, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 31, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 31, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 2, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 2, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 26, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 24, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 24, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 24, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 2, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 12, 2022 | NWAP | NEW APPLICATION ENTERED | — |